A phase I study of recombinant interleukin 2 plus recombinant beta-interferon.

Krigel, R L

A phase I study of recombinant interleukin 2 plus recombinant beta-interferon. [electronic resource] - Cancer research Jul 1988 - 3875-81 p. digital

Publication Type: Journal Article

0008-5472


Adult
Antibodies--analysis
Cytotoxicity, Immunologic
Drug Evaluation
Humans
Immunity, Cellular
Immunotherapy
Interferon Type I--administration & dosage
Interferon-gamma--blood
Interleukin-2--administration & dosage
Killer Cells, Natural--immunology
Lymphocyte Activation
Neoplasms--therapy